These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22348254)
41. Effect of particle size on the dispersion behavior of magnesium stearate blended with microcrystalline cellulose. Puckhaber D; Finke JH; David S; Gururajan B; Rane S; Kwade A Int J Pharm; 2024 Feb; 651():123792. PubMed ID: 38190952 [TBL] [Abstract][Full Text] [Related]
42. Characterization of Synthesized and Commercial Forms of Magnesium Stearate Using Differential Scanning Calorimetry, Thermogravimetric Analysis, Powder X-Ray Diffraction, and Solid-State NMR Spectroscopy. Delaney SP; Nethercott MJ; Mays CJ; Winquist NT; Arthur D; Calahan JL; Sethi M; Pardue DS; Kim J; Amidon G; Munson EJ J Pharm Sci; 2017 Jan; 106(1):338-347. PubMed ID: 27836109 [TBL] [Abstract][Full Text] [Related]
43. Application of external lubrication during the roller compaction of adhesive pharmaceutical formulations. Dawes J; Allenspach C; Gamble JF; Greenwood R; Robbins P; Tobyn M Pharm Dev Technol; 2013 Feb; 18(1):246-56. PubMed ID: 22813432 [TBL] [Abstract][Full Text] [Related]
44. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol. Kuno Y; Kojima M; Nakagami H; Yonemochi E; Terada K Eur J Pharm Biopharm; 2008 Aug; 69(3):986-92. PubMed ID: 18396020 [TBL] [Abstract][Full Text] [Related]
45. Quantification of lubricant activity of magnesium stearate by atomic force microscopy. Weber D; Pu Y; Cooney CL Drug Dev Ind Pharm; 2008 Oct; 34(10):1097-9. PubMed ID: 18777241 [TBL] [Abstract][Full Text] [Related]
46. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib. He X; Barone MR; Marsac PJ; Sperry DC Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339 [TBL] [Abstract][Full Text] [Related]
47. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. Pabari RM; Ramtoola Z Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631 [TBL] [Abstract][Full Text] [Related]
48. [The dry binders, Vivapur 102, Vivapur 12 and the effect of magnesium stearate on the strength of tablets containing these substances]. Muzíková J; Horácek J Ceska Slov Farm; 2003 Jul; 52(4):176-80. PubMed ID: 12924068 [TBL] [Abstract][Full Text] [Related]
49. A comparative study of glycerin fatty acid ester and magnesium stearate on the dissolution of acetaminophen tablets using the analysis of available surface area. Uchimoto T; Iwao Y; Takahashi K; Tanaka S; Agata Y; Iwamura T; Miyagishima A; Itai S Eur J Pharm Biopharm; 2011 Aug; 78(3):492-8. PubMed ID: 21284955 [TBL] [Abstract][Full Text] [Related]
50. Sodium lauryl sulfate as lubricant in tablets formulations: Is it worth? Sabbatini B; Romano Perinelli D; Filippo Palmieri G; Cespi M; Bonacucina G Int J Pharm; 2023 Aug; 643():123265. PubMed ID: 37482231 [TBL] [Abstract][Full Text] [Related]
51. Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets. Hamad ML; Gupta A; Shah RB; Lyon RC; Sayeed VA; Khan MA J Pharm Sci; 2008 Dec; 97(12):5328-40. PubMed ID: 18351597 [TBL] [Abstract][Full Text] [Related]
52. Critical factors in the release of drugs from sustained release hydrophilic matrices. Maderuelo C; Zarzuelo A; Lanao JM J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624 [TBL] [Abstract][Full Text] [Related]
53. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302 [TBL] [Abstract][Full Text] [Related]
54. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug. Kikuchi S; Takayama K Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427 [TBL] [Abstract][Full Text] [Related]
56. Impact of alternative lubricants on process and tablet quality for direct compression. de Backere C; Quodbach J; De Beer T; Vervaet C; Vanhoorne V Int J Pharm; 2022 Aug; 624():122012. PubMed ID: 35839984 [TBL] [Abstract][Full Text] [Related]
57. Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion. Démuth B; Farkas A; Balogh A; Bartosiewicz K; Kállai-Szabó B; Bertels J; Vigh T; Mensch J; Verreck G; Van Assche I; Marosi G; Nagy ZK J Pharm Sci; 2016 Sep; 105(9):2982-2988. PubMed ID: 27290626 [TBL] [Abstract][Full Text] [Related]
58. Development and optimization of a sublingual tablet formulation for physostigmine salicylate. Bolourchian N; Hadidi N; Foroutan SM; Shafaghi B Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826 [TBL] [Abstract][Full Text] [Related]
59. Exploring magnesium myristate for its dual functionality as a binder and lubricant in the formulation of tablet. Pockle R; Masareddy R; Bambulkar V; Desai R; Kiran S Ther Deliv; 2024 Apr; 15(4):253-266. PubMed ID: 38420754 [No Abstract] [Full Text] [Related]
60. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction. Chansanroj K; Betz G Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]